17 results on '"Serrano-Viñuales, Itziar"'
Search Results
2. Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III
- Author
-
Vestager, Maria Linander; https://orcid.org/0000-0002-3273-0791, Hansen, Mathias Lühr; https://orcid.org/0000-0003-1957-7005, Greisen, Gorm, Pellicer, Adelina, Chathasaigh, Caitriona Ni, Lecart, Chantal, Knoepfli, Claudia, Hagmann, Cornelia; https://orcid.org/0000-0003-2647-9809, Gallo, Dario, Ergenekon, Ebru, Hatzidaki, Eleftheria, Dempsey, Eugene, Papathoma, Evangelina, Dimitrou, Gabriel, Pichler, Gerhard; https://orcid.org/0000-0003-2405-7143, Hahn, Gitte Holst, Naulaers, Gunnar, Fuchs, Hans; https://orcid.org/0000-0003-1303-3699, Ozkan, Hilal, de las Cuevas, Isabel, Serrano-Viñuales, Itziar, Sirc, Jan, de Buyst, Julie, Sarafidis, Kosmos, Arrusa, Luis, Baserga, Mariana, Stocker, Martin; https://orcid.org/0000-0002-1461-333X, Cetinkaya, Merih, Alsina-Casanova, Miguel; https://orcid.org/0000-0002-0139-7279, Fumagalli, Monica, et al, Vestager, Maria Linander; https://orcid.org/0000-0002-3273-0791, Hansen, Mathias Lühr; https://orcid.org/0000-0003-1957-7005, Greisen, Gorm, Pellicer, Adelina, Chathasaigh, Caitriona Ni, Lecart, Chantal, Knoepfli, Claudia, Hagmann, Cornelia; https://orcid.org/0000-0003-2647-9809, Gallo, Dario, Ergenekon, Ebru, Hatzidaki, Eleftheria, Dempsey, Eugene, Papathoma, Evangelina, Dimitrou, Gabriel, Pichler, Gerhard; https://orcid.org/0000-0003-2405-7143, Hahn, Gitte Holst, Naulaers, Gunnar, Fuchs, Hans; https://orcid.org/0000-0003-1303-3699, Ozkan, Hilal, de las Cuevas, Isabel, Serrano-Viñuales, Itziar, Sirc, Jan, de Buyst, Julie, Sarafidis, Kosmos, Arrusa, Luis, Baserga, Mariana, Stocker, Martin; https://orcid.org/0000-0002-1461-333X, Cetinkaya, Merih, Alsina-Casanova, Miguel; https://orcid.org/0000-0002-0139-7279, Fumagalli, Monica, and et al
- Abstract
Background The process of obtaining prior informed consent for experimental treatment does not fit well into the clinical reality of acute and intensive care. The therapeutic window of interventions is often short, which may reduce the validity of the consent and the rate of enrolled participants, to delay trial completion and reduce the external validity of the results. Deferred consent and ‘opt-out’ are alternative consent methods. The SafeBoosC-III trial was a randomised clinical trial investigating the benefits and harms of cerebral oximetry monitoring in extremely preterm infants during the first 3 days after birth, starting within the first 6 h after birth. Prior, deferred and opt-out consent were all allowed by protocol. This study aimed to evaluate the use of different consent methods in the SafeBoosC-III trial, Furthermore, we aimed to describe and analyse concerns or complaints that arose during the first 6 months of trial conduct. Methods All 70 principal investigators were invited to join this descriptive ancillary study. Each principal investigator received a questionnaire on the use of consent methods in their centre during the SafeBoosC-III trial, including the possibility to describe any concerns related to the consent methods used during the first 6 months of the trial, as raised by the parents or the clinical staff. Results Data from 61 centres were available. In 43 centres, only prior informed consent was used: in seven, only deferred consent. No centres used the opt-out method only, but five centres used prior and deferred, five used prior, deferred and opt-out (all possibilities) and one used both deferred and opt-out. Six centres applied to use the opt-out method by their local research ethics committee but were denied using it. One centre applied to use deferred consent but was denied. There were only 23 registered concerns during the execution of the trial. Conclusions Consent by opt-out was allowed by the protocol in this multinational trial
- Published
- 2024
3. Cerebral Oximetry Monitoring in Extremely Preterm Infants
- Author
-
Hansen, Mathias L., primary, Pellicer, Adelina, additional, Hyttel-Sørensen, Simon, additional, Ergenekon, Ebru, additional, Szczapa, Tomasz, additional, Hagmann, Cornelia, additional, Naulaers, Gunnar, additional, Mintzer, Jonathan, additional, Fumagalli, Monica, additional, Dimitriou, Gabriel, additional, Dempsey, Eugene, additional, Tkaczyk, Jakub, additional, Cheng, Guoqiang, additional, Fredly, Siv, additional, Heuchan, Anne M., additional, Pichler, Gerhard, additional, Fuchs, Hans, additional, Nesargi, Saudamini, additional, Hahn, Gitte H., additional, Piris-Borregas, Salvador, additional, Širc, Jan, additional, Alsina-Casanova, Miguel, additional, Stocker, Martin, additional, Ozkan, Hilal, additional, Sarafidis, Kosmas, additional, Hopper, Andrew O., additional, Karen, Tanja, additional, Rzepecka-Weglarz, Beata, additional, Oguz, Serife S., additional, Arruza, Luis, additional, Memisoglu, Asli C., additional, del Rio Florentino, Ruth, additional, Baserga, Mariana, additional, Maton, Pierre, additional, Truttmann, Anita C., additional, de las Cuevas, Isabel, additional, Agergaard, Peter, additional, Zafra, Pamela, additional, Bender, Lars, additional, Lauterbach, Ryszard, additional, Lecart, Chantal, additional, de Buyst, Julie, additional, El-Khuffash, Afif, additional, Curley, Anna, additional, Vaccarello, Olalla O., additional, Miletin, Jan, additional, Papathoma, Evangelia, additional, Vesoulis, Zachary, additional, Vento, Giovanni, additional, Cornette, Luc, additional, Lopez, Laura S., additional, Yasa, Beril, additional, Klamer, Anja, additional, Agosti, Massimo, additional, Baud, Olivier, additional, Mastretta, Emmanuele, additional, Cetinkaya, Merih, additional, McCall, Karen, additional, Zeng, Shujuan, additional, Hatzidaki, Eleftheria, additional, Bargiel, Agata, additional, Marciniak, Sylwia, additional, Gao, Xiaoyan, additional, Huijia, Lin, additional, Chalak, Lina, additional, Yang, Ling, additional, Rao, Shashidhar A., additional, Xu, Xin, additional, Gonzalez, Begoña L., additional, Wilinska, Maria, additional, Yin, Zhaoqing, additional, Sadowska-Krawczenko, Iwona, additional, Serrano-Viñuales, Itziar, additional, Krolak-Olejnik, Barbara, additional, Ybarra, Marta M., additional, Morales-Betancourt, Catalina, additional, Korček, Peter, additional, Teresa-Palacio, Marta, additional, Mosca, Fabio, additional, Hergenhan, Anja, additional, Koksal, Nilgun, additional, Tsoni, Konstantia, additional, Kadri, Munaf M., additional, Knöpfli, Claudia, additional, Rafinska-Wazny, Elzbieta, additional, Akin, Mustafa S., additional, Nordvik, Tone, additional, Peng, Zhang, additional, Kersin, Sinem G., additional, Thewissen, Liesbeth, additional, Alarcon, Ana, additional, Healy, David, additional, Urlesberger, Berndt, additional, Baş, Münevver, additional, Baumgartner, Jana, additional, Skylogianni, Eleni, additional, Karadyova, Veronika, additional, Valverde, Eva, additional, Bergon-Sendin, Elena, additional, Kucera, Jachym, additional, Pisoni, Silvia, additional, Wang, Le, additional, Smits, Anne, additional, Sanchez-Salmador, Rebeca, additional, Rasmussen, Marie I., additional, Olsen, Markus H., additional, Jensen, Aksel K., additional, Gluud, Christian, additional, Jakobsen, Janus C., additional, and Greisen, Gorm, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Cerebral Oximetry Monitoring in Extremely Preterm Infants
- Author
-
Hansen, Mathias L., Pellicer, Adelina, Hyttel-Sørensen, Simon, Ergenekon, Ebru, Szczapa, Tomasz, Hagmann, Cornelia, Naulaers, Gunnar, Mintzer, Jonathan, Fumagalli, Monica, Dimitriou, Gabriel, Dempsey, Eugene, Tkaczyk, Jakub, Cheng, Guoqiang, Fredly, Siv, Heuchan, Anne M., Pichler, Gerhard, Fuchs, Hans, Nesargi, Saudamini, Hahn, Gitte H., Piris-Borregas, Salvador, Širc, Jan, Alsina-Casanova, Miguel, Stocker, Martin, Ozkan, Hilal, Sarafidis, Kosmas, Hopper, Andrew O., Karen, Tanja, Rzepecka-Weglarz, Beata, Oguz, Serife S., Arruza, Luis, Memisoglu, Asli C., Del Rio Florentino, Ruth, Baserga, Mariana, Maton, Pierre, Truttmann, Anita C., De Las Cuevas, Isabel, Agergaard, Peter, Zafra, Pamela, Bender, Lars, Lauterbach, Ryszard, Lecart, Chantal, De Buyst, Julie, El-Khuffash, Afif, Curley, Anna, Vaccarello, Olalla O., Miletin, Jan, Papathoma, Evangelia, Vesoulis, Zachary, Vento, Giovanni, Cornette, Luc, Lopez, Laura S., Yasa, Beril, Klamer, Anja, Agosti, Massimo, Baud, Olivier, Mastretta, Emmanuele, Cetinkaya, Merih, McCall, Karen, Zeng, Shujuan, Hatzidaki, Eleftheria, Bargiel, Agata, Marciniak, Sylwia, Gao, Xiaoyan, Huijia, Lin, Chalak, Lina, Yang, Ling, Rao, Shashidhar A., Xu, Xin, Gonzalez, Begoña L., Wilinska, Maria, Yin, Zhaoqing, Sadowska-Krawczenko, Iwona, Serrano-Viñuales, Itziar, Krolak-Olejnik, Barbara, Ybarra, Marta M., Morales-Betancourt, Catalina, Korček, Peter, Teresa-Palacio, Marta, Mosca, Fabio, Hergenhan, Anja, Koksal, Nilgun, Tsoni, Konstantia, Kadri, Munaf M., Knöpfli, Claudia, Rafinska-Wazny, Elzbieta, Akin, Mustafa S., Nordvik, Tone, Peng, Zhang, Kersin, Sinem G., Thewissen, Liesbeth, Alarcon, Ana, Healy, David, Urlesberger, Berndt, Baş, Münevver, Baumgartner, Jana, Skylogianni, Eleni, Karadyova, Veronika, Valverde, Eva, Bergon-Sendin, Elena, Kucera, Jachym, Pisoni, Silvia, Wang, Le, Smits, Anne, Sanchez-Salmador, Rebeca, Rasmussen, Marie I., Olsen, Markus H., Jensen, Aksel K., Gluud, Christian, Jakobsen, Janus C., Greisen, Gorm, Hansen, Mathias L., Pellicer, Adelina, Hyttel-Sørensen, Simon, Ergenekon, Ebru, Szczapa, Tomasz, Hagmann, Cornelia, Naulaers, Gunnar, Mintzer, Jonathan, Fumagalli, Monica, Dimitriou, Gabriel, Dempsey, Eugene, Tkaczyk, Jakub, Cheng, Guoqiang, Fredly, Siv, Heuchan, Anne M., Pichler, Gerhard, Fuchs, Hans, Nesargi, Saudamini, Hahn, Gitte H., Piris-Borregas, Salvador, Širc, Jan, Alsina-Casanova, Miguel, Stocker, Martin, Ozkan, Hilal, Sarafidis, Kosmas, Hopper, Andrew O., Karen, Tanja, Rzepecka-Weglarz, Beata, Oguz, Serife S., Arruza, Luis, Memisoglu, Asli C., Del Rio Florentino, Ruth, Baserga, Mariana, Maton, Pierre, Truttmann, Anita C., De Las Cuevas, Isabel, Agergaard, Peter, Zafra, Pamela, Bender, Lars, Lauterbach, Ryszard, Lecart, Chantal, De Buyst, Julie, El-Khuffash, Afif, Curley, Anna, Vaccarello, Olalla O., Miletin, Jan, Papathoma, Evangelia, Vesoulis, Zachary, Vento, Giovanni, Cornette, Luc, Lopez, Laura S., Yasa, Beril, Klamer, Anja, Agosti, Massimo, Baud, Olivier, Mastretta, Emmanuele, Cetinkaya, Merih, McCall, Karen, Zeng, Shujuan, Hatzidaki, Eleftheria, Bargiel, Agata, Marciniak, Sylwia, Gao, Xiaoyan, Huijia, Lin, Chalak, Lina, Yang, Ling, Rao, Shashidhar A., Xu, Xin, Gonzalez, Begoña L., Wilinska, Maria, Yin, Zhaoqing, Sadowska-Krawczenko, Iwona, Serrano-Viñuales, Itziar, Krolak-Olejnik, Barbara, Ybarra, Marta M., Morales-Betancourt, Catalina, Korček, Peter, Teresa-Palacio, Marta, Mosca, Fabio, Hergenhan, Anja, Koksal, Nilgun, Tsoni, Konstantia, Kadri, Munaf M., Knöpfli, Claudia, Rafinska-Wazny, Elzbieta, Akin, Mustafa S., Nordvik, Tone, Peng, Zhang, Kersin, Sinem G., Thewissen, Liesbeth, Alarcon, Ana, Healy, David, Urlesberger, Berndt, Baş, Münevver, Baumgartner, Jana, Skylogianni, Eleni, Karadyova, Veronika, Valverde, Eva, Bergon-Sendin, Elena, Kucera, Jachym, Pisoni, Silvia, Wang, Le, Smits, Anne, Sanchez-Salmador, Rebeca, Rasmussen, Marie I., Olsen, Markus H., Jensen, Aksel K., Gluud, Christian, Jakobsen, Janus C., and Greisen, Gorm
- Abstract
BACKGROUND The use of cerebral oximetry monitoring in the care of extremely preterm infants is increasing. However, evidence that its use improves clinical outcomes is lacking. METHODS In this randomized, phase 3 trial conducted at 70 sites in 17 countries, we assigned extremely preterm infants (gestational age, <28 weeks), within 6 hours after birth, to receive treatment guided by cerebral oximetry monitoring for the first 72 hours after birth or to receive usual care. The primary outcome was a composite of death or severe brain injury on cerebral ultrasonography at 36 weeks’ postmenstrual age. Serious adverse events that were assessed were death, severe brain injury, bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and late-onset sepsis. RESULTS A total of 1601 infants underwent randomization and 1579 (98.6%) were evaluated for the primary outcome. At 36 weeks’ postmenstrual age, death or severe brain injury had occurred in 272 of 772 infants (35.2%) in the cerebral oximetry group, as compared with 274 of 807 infants (34.0%) in the usual-care group (relative risk with cerebral oximetry, 1.03; 95% confidence interval, 0.90 to 1.18; P=0.64). The incidence of serious adverse events did not differ between the two groups. CONCLUSIONS In extremely preterm infants, treatment guided by cerebral oximetry monitoring for the first 72 hours after birth was not associated with a lower incidence of death or severe brain injury at 36 weeks’ postmenstrual age than usual care. (Funded by the Elsass Foundation and others; SafeBoosC-III ClinicalTrials.gov number, NCT03770741. opens in new tab.), Background The use of cerebral oximetry monitoring in the care of extremely preterm infants is increasing. However, evidence that its use improves clinical outcomes is lacking. Methods In this randomized, phase 3 trial conducted at 70 sites in 17 countries, we assigned extremely preterm infants (gestational age, <28 weeks), within 6 hours after birth, to receive treatment guided by cerebral oximetry monitoring for the first 72 hours after birth or to receive usual care. The primary outcome was a composite of death or severe brain injury on cerebral ultrasonography at 36 weeks' postmenstrual age. Serious adverse events that were assessed were death, severe brain injury, bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and late-onset sepsis. Results A total of 1601 infants underwent randomization and 1579 (98.6%) were evaluated for the primary outcome. At 36 weeks' postmenstrual age, death or severe brain injury had occurred in 272 of 772 infants (35.2%) in the cerebral oximetry group, as compared with 274 of 807 infants (34.0%) in the usual-care group (relative risk with cerebral oximetry, 1.03; 95% confidence interval, 0.90 to 1.18; P=0.64). The incidence of serious adverse events did not differ between the two groups. Conclusions In extremely preterm infants, treatment guided by cerebral oximetry monitoring for the first 72 hours after birth was not associated with a lower incidence of death or severe brain injury at 36 weeks' postmenstrual age than usual care. (Funded by the Elsass Foundation and others; SafeBoosC-III ClinicalTrials.gov number, NCT03770741.).
- Published
- 2023
5. Additional file 1 of Right ventricle speckle tracking in bronchopulmonary dysplasia: one-year follow-up
- Author
-
Clavero-Adell, Marcos, Palanca-Arias, Daniel, López-Ramón, Marta, Jimenez-Montañés, Lorenzo, Serrano-Viñuales, Itziar, Rite-Gracia, Segundo, and Ayerza-Casas, Ariadna
- Abstract
Additional file 1. Echocardiographic measurements at the three timepoints. Classification according to the presence of a significant patent ductus arteriosus (PDA) which needed treatment (drugs or surgery). Mean (Standard Deviation) for parametric variables and T-Student test for comparison between groups (p value). Median [interquartile range Q1; Q3] for non-parametric variables and U-Mann-Whitney test for comparison between groups (p value).
- Published
- 2023
- Full Text
- View/download PDF
6. “Right Ventricle Speckle Tracking in Bronchopulmonary Dysplasia: One Year Follow Up”
- Author
-
Clavero-Adell, Marcos, primary, Palanca-Arias, Daniel, additional, López-Ramón, Marta, additional, Jiménez-Montañés, Lorenzo, additional, Serrano-Viñuales, Itziar, additional, Rite-Gracia, Segundo, additional, and Ayerza-Casas, Ariadna, additional
- Published
- 2021
- Full Text
- View/download PDF
7. Attention Deficit Disorder in the Neuropediatric Outpatient Clinic. Our Current Experience with Children Over Seven and a Half Years Old
- Author
-
Pisón, Javier López, primary, Pisón, Javier López, additional, Serrano-Viñuales, Itziar, additional, de Garayalde, Leyre Troyas-Fernández, additional, Cuadrado-Piqueras, Laura, additional, Jiménez-Olmos, Ainhoa, additional, and Sánchez-Marco, Silvia, additional
- Published
- 2020
- Full Text
- View/download PDF
8. Postinfectious rapidly progressive glomerulonephritis in a pediatric patient
- Author
-
Serrano Viñuales, Itziar, Ruiz del Olmo Izuzquiza, Ignacio, Romero Salas, Yolanda, Montaner Ramón, Alicia, and Justa Roldán, M. Luisa
- Subjects
Corticoides ,Rapidly progressive glomerulonephritis ,Postinfectious ,Pediatría ,Corticoids ,Immunosuppressive agents ,Glomerulonefritis rápidamente progresiva ,Inmunosupresores ,Pediatrics ,Posinfecciosa - Abstract
La glomerulonefritis rápidamente progresiva de etiología posinfecciosa es rara en la infancia, con una prevalencia estimada del 1-3 %. La mayoría debuta como insuficiencia renal aguda y su tratamiento se basa en el uso de corticoides y ciclofosfamida. Si se realiza diagnóstico precoz, el 70 % presenta una recuperación temprana de la función renal. En los últimos años, se han descrito "glomerulopatías por C3", que presentan características que se superponen. Son útiles, en el diagnóstico diferencial, la inmunofluorescencia y la determinación del factor nefrítico. Se presenta un varón de 4 años que acude por fiebre y cuadro respiratorio. Se observa microhematuria, proteinuria, descenso de filtrado glomerular y descenso de C3, y se sospecha glomerulonefritis aguda. Se realiza una biopsia, cuya microscopía óptica muestra la presencia de semilunas epiteliales, y la electrónica, depósitos subepiteliales en forma de joroba, por lo que se diagnostica glomerulonefritis rápidamente progresiva de etiología posinfecciosa. Postinfectious glomerulonephritis is rarely presented as rapidly progressive glomerulonephritis in children; the prevalence is approximately 1-3 %. Most children have acute onset of renal failure; initial treatment involves corticosteroids and immunosuppressive therapy. Early diagnosis improves prognosis. In recent years, an entity known as "C3 glomerulopathies" has been described, presenting characteristics that overlap. In the differential diagnosis, the immunofluorescence and the determination of the nephritic factor are useful. We report a 4-year-old boy with fever, respiratory symptoms and hyporexia. Microhematuria, proteinuria, decline in glomerular filtration and depressed C3 were found. Acute glomerulonephritis was suspected. Renal biopsy showed crescent formation, immunofluorescence staining for C3 and subepithelial humps. Therefore, postinfectious glomerulonephritis with crescent formations was diagnosed.
- Published
- 2019
9. Estenosis de la arteria renal unilateral de diagnóstico neonatal
- Author
-
Barbed Ferrández, Sara M, Martínez Redondo, Inés, Serrano Viñuales, Itziar, Fernández Espuelas, Cristina, Romero Salas, Yolanda, and Gutiérrez Alonso, Cristina
- Subjects
Renal artery stenosis ,Recién nacido ,Hipertensión ,Hypertension ,Hipertensión renovascular ,Renovascular hypertension ,Infant newborn ,Estenosis de la arteria renal - Abstract
La estenosis de la arteria renal es una causa rara de hipertensión arterial neonatal de origen renovascular. Hay muy pocos casos descritos en la literatura en esta etapa. La mayor parte de los pacientes con esta afectación permanecen asintomáticos, y la hipertensión se detecta en las revisiones pediátricas rutinarias. El diagnóstico puede realizarse mediante la combinación de hallazgos bioquímicos y radiológicos. El manejo inicial del paciente se basa en terapia farmacológica hasta alcanzar un crecimiento adecuado para evaluar la reparación definitiva de la lesión vascular o la nefrectomía en caso de supresión funcional del riñón afecto. Se presenta a una paciente femenina recién nacida a término, con hipertensión arterial e importante falla cardíaca congestiva, originada por una estenosis unilateral de la arteria renal, con supresión funcional y atrofia del riñón afecto, que precisó importante soporte inotrópico y antihipertensivo durante los primeros días de vida, con importante mejoría clínica posterior. Renal artery stenosis represents a rare cause of neonatal arterial hypertension of renovascular origin, having been described few cases in the literature at this stage of life. Most patients with this disease remain asymptomatic; hypertension can be detected in routine pediatric revisions. Diagnosis can be performed by combining biochemical and radiological findings. The initial management consists of pharmacological therapy in order to achieve adequate growth. Subsequently, it is necessary to assess definitive repair of the vascular lesion or nephrectomy in the case of functional abolition of the affected kidney. We present a term newborn female, with arterial hypertension and an important congestive heart failure, caused by a unilateral renal artery stenosis, with functional abolition and atrophy of the affected kidney, which required an important inotropic and antihypertensive support during her first days of life, with significant clinical improvement subsequently.
- Published
- 2018
10. Neurofibromatosis tipo 1 y trastorno por déficit de atención. Nuestra experiencia actual
- Author
-
Sánchez Marco, Silvia Beatriz, primary, López Pisón, Javier, additional, Serrano Viñuales, Itziar, additional, Troyas Fernández de Garayalde, Leire, additional, Lafuente Hidalgo, Miguel, additional, and Monge Galindo, Lorena, additional
- Published
- 2019
- Full Text
- View/download PDF
11. Síndrome de Ballantyne: segundo episodio en una embarazada. Reporte de caso y revisión de la bibliografía.
- Author
-
Agustín-Oliva, Andrea, Serrano-Viñuales, Itziar, de Bonrostro-Torralba, Carlos, Herrero-Serrano, Rebeca, Garrido-Fernández, Pilar, and Manuel Campillos-Maza, José
- Subjects
MIRROR syndrome ,PREGNANT women ,PREGNANCY ,POLYHYDRAMNIOS ,HYDROPS fetalis - Abstract
Copyright of Ginecología y Obstetricia de México is the property of Federacion Mexicana de Ginecologia y Obstetricia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2019
- Full Text
- View/download PDF
12. Propéptido natriurético cerebral como marcador de evolución digestiva en el recién nacido prematuro
- Author
-
Montaner Ramón, Alicia, primary, Serrano Viñuales, Itziar, additional, Jiménez Montañés, Lorenzo, additional, Ruiz De La Cuesta Martín, Carmen, additional, Samper Villagrasa, María Pilar, additional, and Rite Gracia, Segundo, additional
- Published
- 2018
- Full Text
- View/download PDF
13. Propéptido natriurético cerebral como marcador de evolución digestiva en el recién nacido prematuro.
- Author
-
Montaner Ramón, Alicia, Serrano Viñuales, Itziar, Jiménez Montañés, Lorenzo, de la Cuesta Martín, Carmen Ruiz, Samper Villagrasa, María Pilar, Rite Gracia, Segundo, and Ruiz de la Cuesta Martín, Carmen
- Abstract
Introduction: Background and objective: hemodynamically significant patent ductus arteriosus (HS-PDA) is associated with an increased risk of necrotizing enterocolitis (NEC) and worse enteral tolerance in preterm newborns (PN). An association has been demonstrated between brain natriuretic propeptide (proBNP) and HS-PDA. Our objective was to analyze the relationship between proBNP levels and enteral tolerance, NEC risk and weight gain in PN. Material and methods: a retrospective study was performed in neonates born before 32 weeks' gestation or with birth weight below 1500 grams, in whom proBNP determination and echocardiography were performed at 48 to 72 h of life. Results: 117 patients were included. 65.8% had a HS-PDA and 9.4% had an outcome of NEC. HS-PDA was associated with longer duration of parenteral nutrition (p < 0.001), a confirmed NEC (p = 0.006) and worse weight gain during admission (p < 0.001). ProBNP levels were associated to NEC (no NEC 12189.5 pg / mL, range 654-247986; NEC 41445 pg/mL, range 15275-166172, p < 0.001). No association was found with the rest of gastrointestinal outcomes. Multivariate logistic regression analysis showed a significant association of NEC with gestational age and proBNP above 22,400 pg/mL (OR 13,386, 95% CI 1,541-116,262, p = 0.019). Conclusions: proBNP could be an early marker of severe digestive pathology in PN. Increased proBNP levels could be associated with a significant increased risk of NEC in very immature newborns. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
14. Utilidad clínica del índice de resistencia cerebral mediante ecografía doppler en el recién nacido. Influencia del DAP hemodinámicamente significativo en el índice de resistencia cerebral
- Author
-
Serrano Viñuales, Itziar, Samper Villagrasa, Pilar, and Rite Gracia, Segundo
- Subjects
índice de resistencia (ir) ,ductus arterioso persistente (dap) ,prematuridad ,ecografía doppler transfontanelar ,recién nacido (rn) - Abstract
OBJETIVO: Analizar el índice de resistencia mediante ecografía doppler cerebral en el recién nacido menor de 32 semanas de edad gestacional y/o menor de 1500g y ver si se ve influenciado por diversas variables perinatales y de evolución neonatal así como estudiar las posibles variaciones del índice de resistencia en los pacientes con ductus arterioso persistente. Además se desea comparar el índice de resistencia del grupo de recién nacidos de muy bajo peso y/o menores de 32 semanas de edad gestacional con un grupo control de recién nacidos a término. MATERIAL Y MÉTODOS: Estudio retrospectivo observacional, descriptivo y analítico mediante la revisión de historias de recién nacidos menores de 32 semanas de edad gestacional y/o menores de 1500g que tuvieran realizado índice de resistencia así como muestra control de recién nacidos a término sin patología asociada y que también tuvieran índice de resistencia realizado. Se analizó la muestra globlal así como por subgrupos en función de la edad gestacional y dentro del subgrupo de los recién nacidos menores de 32 semanas en función de las patologías asociadas con el programa estadístico SPSS 20.0 RESULTADOS: El índice de resistencia medio de la muestra total en función de la edad postnatal es: primeras 72 horas 0,72 ± 0,11, primera semana de vida 0,77 ± 0,11, segunda semana de vida en 0,79 ± 0,07, tercera semana de vida en 0,82 ± 0,08 y más allá de la tercera semana de vida en 0,81 ± 0,09. Al analizarlo en función de la edad gestacional, el grupo pretérmino presenta un índice de resistencia de 0,72 ± 0,13 y en los recién nacidos a término 0,74 ± 0,07 sin encontrarse diferencias estadísticamente significativas entre ambos grupos. No se han encontrado diferencias estadísticamente significativas en función del peso, sexo, necesidad de oxigenoterapia, hemorragia intraventricular, displasia broncopulmonar y necesidad de transfusiones. El índice de resistencia medio en el ductus arterioso persistente es de 0,89 y es superior a los casos en los que no existe ductus arterioso persistente de manera estadísticamente significativa. El índice de resistencia previo al cierre del ductus es de 0,89 frente a 0,74 de manera estadísticamente significativa. CONCLUSIONES: El índice de resistencia tiende a aumentar en los días de vida postnatal no siendo esto estadísticamente significativo. El índice de resistencia no se modifica con la edad gestacional así como con el resto de variables perinatales estudiadadas a excepción del ductus arterioso persistente donde aumenta (0,89) de manera considereble y disminuye tras el tratamiento del mismo por lo que sería un parámetro útil en la toma de decisiones en esta patología
- Published
- 2014
15. [Postinfectious rapidly progressive glomerulonephritis in a pediatric patient].
- Author
-
Serrano Viñuales I, Ruiz Del Olmo Izuzquiza I, Romero Salas Y, Montaner Ramón A, and Justa Roldán ML
- Subjects
- Acute Disease, Child, Preschool, Disease Progression, Glomerulonephritis diagnosis, Humans, Male, Time Factors, Glomerulonephritis microbiology
- Abstract
Postinfectious glomerulonephritis is rarely presented as rapidly progressive glomerulonephritis in children; the prevalence is approximately 1-3 %. Most children have acute onset of renal failure; initial treatment involves corticosteroids and immunosuppressive therapy. Early diagnosis improves prognosis. In recent years, an entity known as "C3 glomerulopathies" has been described, presenting characteristics that overlap. In the differential diagnosis, the immunofluorescence and the determination of the nephritic factor are useful. We report a 4-year-old boy with fever, respiratory symptoms and hyporexia. Microhematuria, proteinuria, decline in glomerular filtration and depressed C3 were found. Acute glomerulonephritis was suspected. Renal biopsy showed crescent formation, immunofluorescence staining for C3 and subepithelial humps. Therefore, postinfectious glomerulonephritis with crescent formations was diagnosed., Competing Interests: The authors report no conflicts of interest in this work., (Sociedad Argentina de Pediatría.)
- Published
- 2019
- Full Text
- View/download PDF
16. [Brain natriuretic peptide as a marker of digestive evolution in the premature newborn].
- Author
-
Montaner Ramón A, Serrano Viñuales I, Jiménez Montañés L, Ruiz de la Cuesta Martín C, Samper Villagrasa MP, and Rite Gracia S
- Subjects
- Biomarkers blood, Ductus Arteriosus, Patent complications, Female, Humans, Infant, Newborn, Male, Parenteral Nutrition, Retrospective Studies, Risk, Weight Gain, Digestive System growth & development, Infant, Premature, Natriuretic Peptide, Brain blood, Peptide Fragments blood
- Abstract
Introduction: Background and objective: hemodynamically significant patent ductus arteriosus (HS-PDA) is associated with an increased risk of necrotizing enterocolitis (NEC) and worse enteral tolerance in preterm newborns (PN). An association has been demonstrated between brain natriuretic propeptide (proBNP) and HS-PDA. Our objective was to analyze the relationship between proBNP levels and enteral tolerance, NEC risk and weight gain in PN. Material and methods: a retrospective study was performed in neonates born before 32 weeks' gestation or with birth weight below 1500 grams, in whom proBNP determination and echocardiography were performed at 48 to 72 h of life. Results: 117 patients were included. 65.8% had a HS-PDA and 9.4% had an outcome of NEC. HS-PDA was associated with longer duration of parenteral nutrition (p < 0.001), a confirmed NEC (p = 0.006) and worse weight gain during admission (p < 0.001). ProBNP levels were associated to NEC (no NEC 12189.5 pg / mL, range 654-247986; NEC 41445 pg/mL, range 15275-166172, p < 0.001). No association was found with the rest of gastrointestinal outcomes. Multivariate logistic regression analysis showed a significant association of NEC with gestational age and proBNP above 22,400 pg/mL (OR 13,386, 95% CI 1,541-116,262, p = 0.019). Conclusions: proBNP could be an early marker of severe digestive pathology in PN. Increased proBNP levels could be associated with a significant increased risk of NEC in very immature newborns.
- Published
- 2019
- Full Text
- View/download PDF
17. [Neonatal diagnosis of unilateral renal artery stenosis].
- Author
-
Barbed Ferrández SM, Martínez Redondo I, Serrano Viñuales I, Fernández Espuelas C, Romero Salas Y, and Gutiérrez Alonso C
- Subjects
- Female, Heart Failure etiology, Humans, Hypertension etiology, Infant, Newborn, Renal Artery Obstruction complications, Heart Failure diagnosis, Hypertension diagnosis, Renal Artery Obstruction diagnosis
- Abstract
Renal artery stenosis represents a rare cause of neonatal arterial hypertension of renovascular origin, having been described few cases in the literature at this stage of life. Most patients with this disease remain asymptomatic; hypertension can be detected in routine pediatric revisions. Diagnosis can be performed by combining biochemical and radiological findings. The initial management consists of pharmacological therapy in order to achieve adequate growth. Subsequently, it is necessary to assess definitive repair of the vascular lesion or nephrectomy in the case of functional abolition of the affected kidney. We present a term newborn female, with arterial hypertension and an important congestive heart failure, caused by a unilateral renal artery stenosis, with functional abolition and atrophy of the affected kidney, which required an important inotropic and antihypertensive support during her first days of life, with significant clinical improvement subsequently., (Sociedad Argentina de Pediatría.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.